3.1.2 Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis Flashcards

1
Q

Name this dz: Target like lesions, <10% of the body affected; Commonly triggered by HSV or mycoplasma

A

Erythema multiforme

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What make Erythroderma and Erythematous Drug Eruptions different from SJS/TEN?

A

Lacks mucosal involvement

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What is a phototoxic eruption?

A

Reaction to recent sun exposure, drug induced

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What are the two key aspects of SJS/TEN?

A

Severe mucocutaneous reactions

Triggered by medications (started 4-8wks prior)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

The SJS/TEN share the same etiology. They only differ based on their severity. Describe when it would be SJS, SJS/TEN overlap, or just TEN?

A

Severity based on body surface area affected.

SJS: <10% affected

SJS/TEN: overlap 10-30% affected

TEN: >30% is affected

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Which is more prevalent SJS or TEN?

A

SJS, 3:1

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What condition can increase one’s risk of SJS/TEN 100-fold?

A

HIV

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What is the most common etiology of SJS/TEN? Give some examples.

A

Medications (1st 4-8 wks of taking the medication)

Allopurinol (treatment of gout), Anti-seizure (phenobarbital and carbamazepine), Antibacterial sulfonamides (TMP-SMX – Bactrim), Lamotrigine (bipolar disease/seizures - Lamictal), Nevirapine (non-nucleoside reverse transcriptase inhibitor – used in the treatment of HIV), Oxicam NSAIDs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What are some infections associated with SJS/TEN?

A

Mycoplasma pneumonia, Cytomegalovirus, Epstein-Barr virus, Mycobacteria, Diphtheria

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What are the two genes that associated w/ an increased risk of SJS/TEN? What is the appropriate course of action when considering a patient’s risk of developing SJS/TEN?

A

HLA-B*1502 (Carbamazepine, phenytoin, phenobarbital) and HLA-B*5801 (Allopurinol)

  1. Consider screening these patients prior to starting the medication
  2. Do not start these medications if patient is a known carrier of one of these mutations
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What are some genetic polymorphisms associated with SJS/TEN?

A

CYP2C19 – coding for cytochrome p450– reduced clearance of medications in the liver and increased risk of severe cutaneous reactions

IL-4R gene

Prostaglandin E receptor 3 gene

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

High levels of which granzyme have been associated with increased severity of SJS/TEN?

A

Granzyme B

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What is granulysin?

A

Antimicrobial and cytotoxic, Expressed by cytotoxic T cells and NK cells, Causes release of caspase 3, Keratinocyte death, Found in blister fluid of lesions

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Describe the histopathologic nature of the necrosis found in SJS/TEN.

A

Partial to full-thickness necrosis of the epidermis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What is the term for the 1-3 days prior to the onset of skin lesions. During this time patients may experience:

§Fever (often >39°C – 102.2°F)

§Flu-like symptoms – malaise, myalgia, arthralgia

§Photophobia (light bothers the eyes)

§Conjunctival itching/burning

§Dysphagia (painful swallowing)

§Exanthematous eruption (red rash)

A

Prodrome

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What can occur in the urogenital region of SNS/TEN patients? It requires aggressive monitoring.

A

Urethritis – leads to urinary retention (up to 65% of cases)

17
Q

What does this patient have?

A

DSLs…

Jk, SJS/TEN

18
Q

What is the clinical course of SJS/TEN?

A

§8-12 days

§Fever

§Severe mucous membrane involvement

§Epidermal sloughing

19
Q

What type of shock are SJS/TEN patients succeptible to?

A

Hypovolemic

20
Q

What is important about med hx relating to a patient with SJS/TEN?

A

§Recent drug exposure or recent illness

§Within the last 4-8 weeks (average of 2 weeks)

§Recurrence of symptoms within 48 hours of restarting the offending medication

21
Q

What would be the direct immunofluorescence results of a SJS/TEN patient?

A

Neg, no Ab desposits

22
Q

What are some of the possible treatment methods for SJS/TEN?

A

High dose steroids

Intravenous immunoglobulin (IVIg)

Cyclosporine

Plasmapheresis

Anti-TNF monoclonal antibodies

(All remain controversial, no good studies)

23
Q
A